Vaxcyte Inc
(PCVX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 152,981 | 114,472 | 196,676 | 113,026 | 87,147 |
| Operating Income | -152,981 | -114,472 | -196,676 | -113,026 | -87,147 |
| Other Income | 24,278 | 19,452 | 15,875 | 20,362 | 18,808 |
| Pre-tax Income | -128,703 | -95,020 | -180,801 | -92,664 | -68,339 |
| Net Income Continuous | -128,703 | -95,020 | -180,801 | -92,664 | -68,339 |
| Net Income | $-128,703 | $-95,020 | $-180,801 | $-92,664 | $-68,339 |
| EPS Basic Total Ops | -1.10 | -0.85 | -1.83 | -0.91 | -0.70 |
| EPS Basic Continuous Ops | -1.10 | -0.85 | -1.83 | -0.91 | -0.70 |
| EPS Diluted Total Ops | -1.10 | -0.85 | -1.83 | -0.91 | -0.70 |
| EPS Diluted Continuous Ops | -1.10 | -0.85 | -1.83 | -0.91 | -0.70 |
| EPS Diluted Before Non-Recurring Items | -1.10 | -0.85 | -1.82 | N/A | N/A |
| EBITDA(a) | $-159,437 | $-122,372 | $-196,097 | $-125,118 | $-96,590 |